CD30 expression in cutaneous B‐cell lymphomas
Journal of Cutaneous Pathology(2023)
摘要
CD30 may be expressed in CBCL, possibly causing diagnostic confusion. CD30 expression was most commonly identified in PCFCL and is associated with favorable clinical features. In cases with strong and diffuse expression, CD30 could be a therapeutic target.
更多查看译文
关键词
B-cell lymphoma, CD30, cutaneous
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要